Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 538 of 1,261
  1. US 10106620

    Blocking CD38 using anti-CD38 F(ab′)2 to protect NK cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  2. US 10106616

    Antagonist antibodies to human prolactin receptor (PRLR)

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  3. US 10104882

    Methods and compositions for preventing and treating electrophile-mediated toxicities

    Montefiore Medical Center · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  4. US 10105316

    Inhalation compositions comprising muscarinic receptor antagonist

    ARVEN ILAC SANAYI VE TICARET A.S. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  5. US 10105379

    Pharmaceutical compositions comprising three antibiotics

    RedHill Biopharma Ltd. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  6. US 10106610

    Antibodies comprising chimeric constant domains

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  7. US 10105391

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted
  8. US 10098887

    Antiviral compounds and methods of use thereof

    TRANA DISCOVERY, INC. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  9. US 10100049

    JAK kinase inhibitor compounds for treatment of respiratory disease

    Theravance Biopharma R&D IP, LLC · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  10. US 10098847

    Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  11. US 10100317

    Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  12. US 10098866

    Pharmaceutical preparation containing copolyvidone

    Takeda Pharmaceutical Company Limited · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  13. US 10100020

    Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases

    United Kingdom Research and Innovation · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  14. US 10098945

    Genetically engineered swine influenza virus and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  15. US 10100012

    Compounds as anti-tubercular agents

    DRUG DISCOVERY RESEARCH CENTRE · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  16. US 10098865

    Multi-arm polymeric prodrug conjugates of taxane-based compounds

    Nektar Therapeutics · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  17. US 10101331

    Methods of evaluating patients using E-cadherin or vimentin

    Agios Pharmaceuticals, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  18. US 10100367

    Diagnosing and monitoring CNS malignancies using microRNA

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  19. US 10100346

    Infectious hepatitis C viruses of genotype 3A and 4A and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  20. US 10100083

    Leukemia stem cell targeting ligands and methods of use

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  21. US 10100310

    Modulation of prekallikrein (PKK) expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  22. US 10100279

    In vitro production of medial ganglionic eminence precursor cells

    The Regents of the University of California · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  23. US 10100089

    Process for the preparation of cyclic depsipeptides

    OnKure, Inc. · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted
  24. US 10100051

    Compound of 5-hydroxyl-1,7-naphthyridine substituted by aryloxy or heteroaryloxy, preparation method thereof and pharmaceutical use thereof

    Shenyang Sunshine Pharmaceutical Co., LTD · Granted Oct 16, 2018 · Expires Oct 11, 2038

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.